2006 Ohio Revised Code - 4725.01. Definitions.

§ 4725.01. Definitions.
 

As used in this chapter: 

(A) (1) The "practice of optometry" means the application of optical principles, through technical methods and devices, in the examination of human eyes for the purpose of ascertaining departures from the normal, measuring their functional powers, adapting optical accessories for the aid thereof, and detecting ocular abnormalities that may be evidence of disease, pathology, or injury. 

(2) In the case of a licensed optometrist who holds a topical ocular pharmaceutical agents certificate, the "practice of optometry" has the same meaning as in division (A)(1) of this section, except that it also includes administering topical ocular pharmaceutical agents for the purposes set forth in division (A)(1) of this section. 

(3) In the case of a licensed optometrist who holds a therapeutic pharmaceutical agents certificate, the "practice of optometry" has the same meaning as in divisions (A)(1) and (2) of this section, except that it also includes employing, applying, administering, and prescribing instruments, devices, procedures other than invasive procedures, and therapeutic pharmaceutical agents for the following purposes: 

(a) Examination, investigation, diagnosis, or prevention of any disease, injury, or other abnormal condition of the visual system; 

(b) Treatment or cure of any disease, injury, or other abnormal condition of the anterior segment of the human eye. 

(B) "Topical ocular pharmaceutical agents" means: 

(1) Proparacaine hydrochloride in a potency not exceeding five-tenths of one per cent ophthalmic solution; 

(2) Benoxinate hydrochloride in a potency not exceeding four-tenths of one per cent ophthalmic solution; 

(3) Phenylephrine hydrochloride in a potency not exceeding two and five-tenths per cent ophthalmic solution; 

(4) Hydroxyamphetamine hydrobromide in a potency not exceeding one per cent ophthalmic solution; 

(5) Tropicamide in a potency not exceeding one per cent ophthalmic solution; 

(6) Cyclopentolate in a potency not exceeding one per cent ophthalmic solution; 

(7) Any other topical ocular pharmaceutical agents if the primary indications for their use are consistent with the purposes set forth in division (A)(1) of this section, their new drug application is approved by and the potency in which they may be used for evaluative purposes has been established by the federal food and drug administration after January 1, 1983, and their use for the purposes set forth in division (A)(1) of this section has been approved by rule of the state board of optometry. 

(C) "Therapeutic pharmaceutical agent" means a topical ocular pharmaceutical agent or any of the following drugs or dangerous drugs that is used for examination, investigation, diagnosis, or prevention of disease, injury, or other abnormal condition of the visual system or for treatment or cure of disease, injury, or other abnormal condition of the anterior segment of the human eye and is an anti-microbial, anti-allergy, anti-glaucoma, topical anti-inflammatory, or cycloplegic agent, or an analgesic: 

(1) A topical ophthalmic preparation; 

(2) Oral dosage of any of the following drugs: 

(a) Acetazolamide; 

(b) Astemizole; 

(c) Dichlorphenamide; 

(d) Diphenhydramine; 

(e) Glycerin in a fifty per cent solution; 

(f) Isosorbide in a forty-five per cent solution; 

(g) Methazolamide; 

(h) Analgesics that may be legally sold without prescription; 

(i) Terfenadine; 

(j) Ampicillin in a two hundred fifty milligram or five hundred milligram dosage; 

(k) Cefaclor in a two hundred fifty milligram or five hundred milligram dosage; 

(l) Cephalexin in a two hundred fifty milligram or five hundred milligram dosage; 

(m) Dicloxacillin in a two hundred fifty milligram or five hundred milligram dosage; 

(n) Doxycycline in a fifty milligram or one hundred milligram dosage; 

(o) Erythromycin in a two hundred fifty milligram, three hundred and thirty-three milligram, or five hundred milligram dosage; 

(p) Penicillin VK in a two hundred fifty milligram or five hundred milligram dosage; 

(q) Tetracycline in a two hundred fifty milligram or five hundred milligram dosage. 

(3) Any other oral dosage of a drug or dangerous drug that is listed by rule adopted by the state board of optometry under section 4725.09 of the Revised Code. 

(D) "Drug" and "dangerous drug" have the same meanings as in section 4729.01 of the Revised Code. 

(E) "Invasive procedure" means any procedure that involves cutting or otherwise infiltrating human tissue by mechanical means including surgery, laser surgery, ionizing radiation, therapeutic ultrasound, administering medication by injection, or the removal of intraocular foreign bodies. 

(F) "Visual system" means the human eye and its accessory or subordinate anatomical parts. 

(G) "Certificate of licensure" means a certificate issued by the state board of optometry under section 4725.13 of the Revised Code authorizing the holder to practice optometry as provided in division (A)(1) of this section. 

(H) "Topical ocular pharmaceutical agents certificate" means a certificate issued by the state board of optometry under section 4725.13 of the Revised Code authorizing the holder to practice optometry as provided in division (A)(2) of this section. 

(I) "Therapeutic pharmaceutical agents certificate" means a certificate issued by the state board of optometry under division (A)(3) or (4) of section 4725.13 of the Revised Code authorizing the holder to practice optometry as provided in division (A)(3) of this section. 
 

HISTORY: GC § 1295-21; 108 v PtI, 73; Bureau of Code Revision, 10-1-53; 140 v S 187 (Eff 6-14-84); 144 v S 110 (Eff 5-19-92); 144 v S 359 (Eff 1-1-93); 147 v S 66 (Eff 7-22-98); 147 v H 553. Eff 3-9-99.